CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 104 filers reported holding CULLINAN ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,720,442 | +84008.7% | 1,074,082 | 0.0% | 0.52% | -3.5% |
| Q2 2023 | $11,557 | +5.2% | 1,074,082 | 0.0% | 0.54% | -0.7% |
| Q1 2023 | $10,988 | -99.9% | 1,074,082 | 0.0% | 0.54% | -9.5% |
| Q4 2022 | $11,331,565 | -17.7% | 1,074,082 | 0.0% | 0.60% | -22.9% |
| Q3 2022 | $13,770,000 | 0.0% | 1,074,082 | 0.0% | 0.77% | -11.2% |
| Q2 2022 | $13,770,000 | +22.4% | 1,074,082 | 0.0% | 0.87% | +50.9% |
| Q1 2022 | $11,246,000 | -32.1% | 1,074,082 | 0.0% | 0.58% | -10.2% |
| Q4 2021 | $16,573,000 | -31.6% | 1,074,082 | 0.0% | 0.64% | -24.0% |
| Q3 2021 | $24,242,000 | -12.4% | 1,074,082 | 0.0% | 0.85% | -13.2% |
| Q2 2021 | $27,658,000 | -38.2% | 1,074,082 | 0.0% | 0.98% | -35.7% |
| Q1 2021 | $44,757,000 | – | 1,074,082 | – | 1.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
| CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
| Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
| Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
| Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
| BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
| Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
| Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
| Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
| Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |